TransCure will be attending Oncology Virtual Partnering, Mar 2nd to Mar 5th

Our CEO, Patrick NEF, will be Online during the Oncology Virtual Partnering, March 2-5.

Connect with our CEO, Patrick NEF to talk about fully-humanized immune system mouse models for immunity-targeted preclinical assessment, here focused on IO.

Learn more about the event here.

Click here to pre-arrange a digital face-to-face :

Who are we?

TransCure bioServices is the European Leader CRO specialized in the Advanced Human Immune System Mouse (hu-mouse) Models. We provides in vivo pharmacology preclinical services for Cancer/Immuno-oncology, HIV, Inflammatory Bowel Diseases, Vaccines/Immunization, Immuno-safety…

Highest needs for the large pharmaceutical and biotechnology companies as well as academic laboratories which can profile new preclinical/clinical drug candidates (small molecules, peptides, biologics, mAb, vaccines) targeting immuno-related diseases for translational potential assessment and better predictive activity in clinical studies.. TransCure bioServices is your one stop shop for in vivo pharmacology preclinical expertise.